Area of research
Cancer Research · Molecular Biology
Research interest
Research interests include Peroxisome Proliferator-Activated Receptors, Cancer, Hypoxia, and Metabolism, Ferroptosis and cancer prognosis, and Cancer-related molecular mechanisms research.
Prospective evidence for the gut–bone axis in osteoporotic fractures: Insights from genetic prediction and metabolite mediators
Single Photon Emission Computed Tomography/X-ray Computed Tomography-based radiomics analysis for diagnosis of bone metastases in patients with breast cancer
Sexually dimorphic control of affective state processing and empathic behaviors
An insular cortical circuit required for itch sensation and aversion
In vivo imaging of alkaline phosphatase in lipid metabolic diseases with a photoacoustic probe
Expression and Significance of BCCIP and Glutathione Peroxidase 4 in Clear Cell Renal Cell Carcinoma
Human umbilical cord mesenchymal stem cell-derived exosomes ameliorate liver steatosis by promoting fatty acid oxidation and reducing fatty acid synthesis
Non-coding RNAs’ function in cancer development, diagnosis and therapy
PPARγ agonist pioglitazone enhances colorectal cancer immunotherapy by inducing PD-L1 autophagic degradation
Inhibition of CK2/ING4 Pathway Facilitates Non‐Small Cell Lung Cancer Immunotherapy
Anticancer applications of phytochemicals in gastric cancer: Effects and molecular mechanism
Exosomal hsa_circ_000200 as a potential biomarker and metastasis enhancer of gastric cancer via miR-4659a/b-3p/HBEGF axis
Exosomal circRNAs in gastrointestinal cancer: Role in occurrence, development, diagnosis and clinical application (Review)
PPARγ agonist inhibits c‐Myc‐mediated colorectal cancer tumor immune escape
Effect of bladder filling status on positioning errors in post-hysterectomy cervical cancer radiotherapy
Identification and validation of a novel cellular senescence-related lncRNA prognostic signature for predicting immunotherapy response in stomach adenocarcinoma
<scp>DPEP1</scp> promotes drug resistance in colon cancer cells by forming a positive feedback loop with <scp>ASCL2</scp>
Identification of TGF-β signaling-related molecular patterns, construction of a prognostic model, and prediction of immunotherapy response in gastric cancer
CD47/SIRPα pathway mediates cancer immune escape and immunotherapy
BDNF produced by cerebral microglia promotes cortical plasticity and pain hypersensitivity after peripheral nerve injury
Role of autophagy on cancer immune escape
AMPK phosphorylates PPARδ to mediate its stabilization, inhibit glucose and glutamine uptake and colon tumor growth
Identification of colon tumor marker NKD1 via integrated bioinformatics analysis and experimental validation
PD-L1 degradation pathway and immunotherapy for cancer
DPEP1 promotes the proliferation of colon cancer cells via the DPEP1/MYC feedback loop regulation
EGFR/PPARδ/HSP90 pathway mediates cancer cell metabolism and chemoresistance
Metformin inhibits PPARδ agonist-mediated tumor growth by reducing Glut1 and SLC1A5 expressions of cancer cells
PPARα agonist alleviates tumor growth and chemo-resistance associated with the inhibition of glucose metabolic pathway
miR‑671‑5p inhibits gastric cancer cell proliferation and promotes cell apoptosis by targeting URGCP
PPARδ agonist enhances colitis-associated colorectal cancer